“We are very pleased that Sharp Laboratories has chosen EFD.V5. For analysis to become an integral step in the design process, it needs to fit within the product development process with minimal disruption to the workflow. Since EFD.V5 is embedded in CATIA V5, Sharp Laboratories can use a single interface for both design and analysis and take advantage of virtual prototyping at the design stage to further improve their market leading products,” said Gary Carter, Flomerics’ CEO.